beta
ACHN
Achillion Pharmaceuticals, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.
Market Cap: 864 Million
Primary Exchange: NASDAQ
Website: http://www.achillion.com
Shares Outstanding: 140 Million
Float: 136 Million
Dividend: (%)
Beta: 1.90062256860271
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1244 trading days
From: 2015-01-23 To: 2019-12-04
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|